INM InMed Pharma: Net earnings per share (EPS TTM)

InMed Pharmaceuticals (INM) - corporate logo

The fundamental TTM net income per share metric highlights the impact of strict FDA oversight and the biosynthesis patent protection of InMed Pharmaceuticals (INM), where the -3.10 level serves as a critical benchmark. InMed Pharmaceuticals is implementing automated bacterial reactors to eliminate human error while simultaneously developing the Integram platform to create safe medications for skin and eye pathologies.

INM InMed Pharmaceuticals Earnings per share for the last 12 months (07/04/2022 - 11/09/2026)

Analytical breakdowns and data insights for company InMed Pharmaceuticals Inc (INM)

- current quotes and average value forecast:
Price Chart InMed Pharmaceuticals|INM - Consensus Target
- company stock capitalization data:
Market Capitalization InMed Pharmaceuticals Inc.|INM - Company Buyout Price
- business book valuation details:
Net Assets per Single Share InMed Pharmaceuticals|INM - Accounting Capitalization|Market Value to Book Value Ratio inmedpharma.com|INM - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital InMed Pharmaceuticals|INM - Long-Term Liabilities to Capital|Short-Term Debt to Capital InMed Pharma|INM - Company Aggregate Debt|Debt to Book Value InMed Pharmaceuticals Inc.|INM - Company Long-Term Loans and Borrowings|Company Short-Term Debt InMed Pharmaceuticals|Quick Ratio inmedpharma.com
- earnings and multiples data:
INM - Final Profit|Projected Future Earnings InMed Pharmaceuticals|INM - P/E Multiple|Future Price to Earnings InMed Pharmaceuticals Inc.|INM - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization InMed Pharmaceuticals Inc.|INM - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) InMed Pharmaceuticals|INM - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth inmedpharma.com|INM - Net earnings per share growth this year|Earnings growth forecast for next year InMed Pharmaceuticals
- sales volume and revenue information:
INM - Company Total Revenue|Company Future Sales Volume InMed Pharmaceuticals|INM - P/S Multiple|Forward Price-to-Revenue Multiple InMed Pharmaceuticals Inc.
Fundamental valuation:InMed Pharmaceuticals - INM
Manufactured products of InMed Pharmaceuticals Inc

To minimize investment risks, it is necessary to evaluate the issuer's actual efficiency in capital generation. This metric is calculated as the ratio of total net income over the last four quarters to the total number of shares outstanding. By analyzing the TTM earnings per share, an investor determines the fundamental value of the business during periods of price stagnation. This trend reflects the financial stability of InMed Pharmaceuticals (INM). The eco-friendly biosynthesis of compounds reduces operating expenses, directly impacting the final profitability of each share.

Competing companies

INDV - Earnings per share for the last twelve months|collegiumpharma.com (COLL) - Net earnings per share for the last 12 months|CRON: Net earnings per share (EPS TTM)|CGC - Net earnings per share for the last four quarters|Earnings per share for the last twelve months High Tide Corp|Earnings per share for the last 12 months ACB (Aurora)|Earnings per share for the last twelve months Achieve Life Sciences (ACHV)|Net earnings per share for the last 12 months Skye Bioscience Inc. SKYE|Net earnings per share (EPS TTM) ANEB (Anebulo Pharmaceuticals, Inc.)|InterCure Ltd (INCR) - Net earnings per one share for the last twelve months|Nutriband Corp - Net earnings per share (EPS TTM)|NSRX (Nasus Pharma Ltd) - Earnings per share for the last 12 months|IGC (igcinc.us) - Net earnings per share for the last 12 months|MIRA Pharmaceuticals, Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Flora Growth|IMC - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) ADIL|ARTL (artelobio.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ENSC (Ensysce Biosciences, Inc.)|Net earnings per share (EPS TTM) Titan Pharmaceuticals Inc. TTNP|GNLN - Earnings per share for the last twelve months|Earnings per share for the trailing year AKAN (Akanda Corp)|Enveric (ENVB) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Bright Green Corporation|HPCO (Hempacco Co., Inc.) - Net earnings per share (EPS TTM)